Loading…

Essential thrombocythemia and pregnancy

Abstract Essential thrombocythaemia (ET) is an acquired myeloproliferative neoplasm, characterised by persistent thrombocytosis and a tendency for either thrombosis or haemorrhage. Among myeloproliferative neoplasms, ET is the most prevalent in young women, which constitute a special group due to th...

Full description

Saved in:
Bibliographic Details
Published in:European Journal of Obstetrics & Gynecology and Reproductive Biology 2011-10, Vol.158 (2), p.141-147
Main Authors: Valera, Marie-Cécile, Parant, Olivier, Vayssiere, Christophe, Arnal, Jean-François, Payrastre, Bernard
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Essential thrombocythaemia (ET) is an acquired myeloproliferative neoplasm, characterised by persistent thrombocytosis and a tendency for either thrombosis or haemorrhage. Among myeloproliferative neoplasms, ET is the most prevalent in young women, which constitute a special group due to their childbearing potential. An increased risk of fetal and maternal complications has been demonstrated in patients with ET. The most common pregnancy-related complication is spontaneous abortion during the first trimester. Recurrent abortion, fetal growth restriction, stillbirth and placental abruption are less frequent. Maternal complications are relatively rare and essentially represented by thromboembolic and bleeding events. Here we summarize the literature describing pregnancy and its outcome in patients with ET and discuss some recommendations for the management of pregnancy.
ISSN:0301-2115
1872-7654
2590-1613
DOI:10.1016/j.ejogrb.2011.04.040